TAPUR

[HopeForJesse]

No charge access to cancer drugs when other lines of treatment are exhausted.

http://www.tapur.org/patients

"ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a non-randomized clinical trial that offers patients access to molecularly targeted cancer drugs and collects real-world data on clinical outcomes to help learn the best uses of these drugs outside of indications approved by the FDA. Since its launch last year, TAPUR has continued to grow, with more than 285 participants registered and more than 100 clinical sites participating as of mid-May. For more information, please visit tapur.org or cancer.net/tapur"

[Lee]

Bump for those who missed this the 1st time.

Lee

[CRguy]

Thought I had posted these links ????

anyway here is more background and discussion on TAPUR which is very POG like in its strategy and implemetations.

Maurie Markman on the Groundbreaking TAPUR Trial

What is the TAPUR Study?

The TAPUR study by ASCO

About the TAPUR Study

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (TAPUR)

This link requires a free registered login to view in its entirety :
ASCO Expands TAPUR Sites; Inks Collaborations to Investigate Precision Oncology Globally

When the study launched over a year ago, TAPUR was enrolling patients into 35 sites. But in the coming months eight new centers at 36 locations will begin to recruit patients, increasing the number of study sites to more than 100 in 20 US states. These sites will offer patients the chance to enroll in study arms investigating 15 targeted treatment options that seven drug companies have provided.

As part of its strategy to expand recruitment efforts, ASCO lowered the eligibility age from 18 years down to 12 years, so that adolescent patients with advanced cancer could join the study. Additionally, ASCO partnered with the Canadian Cancer Trials Group and the WIN Consortium, which are developing studies based on the TAPUR basket design. ASCO, WIN, and CCTG will share study results to improve understanding of genomically defined treatment strategies.

[KElizabeth]

Following. There's actually an Omaha location. I'm intrigued now.